MedPath

Clinical Study to Investigate the Effect of the Functional Food on Improving Minor Health Complaints: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000048849
Lead Sponsor
Hokkaido Information University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

1.Subjects who are under physician's advice, treatment, and/or medication for schizophrenia, depression, mania, neurological disorders, sleep disorders, and/or chronic fatigue syndrome. 2.Subjects who receive nourishment instruction. 3.Subjects with implantable electronic medical devices. 4.Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities. 5.Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 6.Subjects with unusually high and/or low blood pressure and/or abnormal hematological data. 7.Subjects with severe anemia. 8.Pre- or post-menopausal women complaining of obvious physical changes. 9.Subjects who are at risk of having allergic reactions to drugs or foods especially based on wheat, soybean, egg, milk, cocoa. 10.Subjects who regularly take medicine, functional foods, and/or supplements which would affect sleep and/or stress. 11.Heavy smokers, alcohol addicts or subjects with disordered lifestyle. 12.Subjects who donated either 400 ml whole blood within 16 wks (women), 12 wks (men), 200 ml whole blood within 4 wks, or blood components within 2 wks, prior to the current study. 13.Pregnant or lactating women or women who expect to be pregnant during this study. 14.Subjects who currently participate in other clinical trials, or participated within the last 4 wks prior to the current study. 15.Subjects whose lifestyle is expected to change significantly. 16.Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Brief Job Stress Questionnaire (Section B) after 4 weeks of ingestion.
Secondary Outcome Measures
NameTimeMethod
Survey on subjects' sleeping, bowel movement, mental and physical condition, sense of accomplishment.
© Copyright 2025. All Rights Reserved by MedPath